UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean balance sheet. See why PATH stock is a buy.

AI is now a tailwind.

UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the OSWorld-Verified benchmark, an ...

Shares of UiPath have come under pressure recently as investors balance optimism around enterprise automation and AI productivity tools with questions about execution and turnaround momentum in a ...

UiPath’s PATH edge in today’s automation race comes down to one thing: how effectively its platform converts AI innovation ...

・CEO and Chairman, Dines Daniel, sold shares worth around $1.5 million earlier in the week. ・He sold 90,000 shares of the company in two tranches and still owns roughly 28.5 million shares. ・Retail ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. UiPath (PATH) is ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

RBC Capital raised its price target for UiPath to $19, citing stabilizing trends, while Truist Securities increased its target to $17, acknowledging the company’s strong top and bottom-line ...